Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Nexeon Medsystems Inc (AKA: Rosellini Scientific LLC)
Profile last edited on: 11/1/2023      CAGE: 6ARU7      UEI: NZGGGMKP6CW4

Business Identifier: Wireless technology, remote monitoring and advanced therapeutic delivery options
Year Founded
2005
First Award
2014
Latest Award
2017
Program Status
Inactive (Acquired)
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

10210 North Central Expressway Suite 105
Dallas, TX 75231
   (214) 414-0454
   info@nexeonmed.com
   www.nexeonmedsystems.com
Location: Single
Congr. District: 24
County: Collin

Public Profile

Nexeon Medsytems Inc, formerly Rosellini Scientific LLC until the firm was acquired by Nexeon Europe in 2017 and now operating as Nexeon Medsystems Inc, is a publically traded medical device company focused on providing innovative neurostimulation products that improve the quality of life of patients suffering from debilitating neurological diseases. The firm's primary technology is a non-invasive, battery-operated device to stimulate the auricular branch of the vagus nerve (ABVN) to reduce the symptoms of various chronic diseases and disorders.

Extent of SBIR involvement

User Avatar
Phase I Awards
4
Phase II Awards
1
Conversion Rate
25.00%
Phase I Dollars
$801,744
Phase II Dollars
$877,192
Total Awarded
$1,678,936

Synopsis: Awardee Business Condition

Employee Range
50-74
Revenue Range
5M-7.5M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
OTC : NXNN
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2017 1 NIH $149,187
Project Title: Vagus Nerve Stimulation Treatment for Asthmatic Bronchoconstriction
2017 2 NIH $1,070,574
Project Title: Development of a Microperforated Nanocomposite Balloon for Intravascular Anti-Restenotic Drug Delivery
2014 1 NIH $213,345
Project Title: Wireless Tibial Nerve Stimulation Therapy for Overactive Bladder
2014 1 NIH $245,830
Project Title: Wireless Vagal Nerve Stimulation System for Treating Atrial Fibrillation

Key People / Management

  Emily Hamilton Rosellini -- President

  Hartmut Spitaels -- President

  Mark Bates

  Eddie Bright

Company News

Jan 17 2017
Rosellini Scientific acquired by Nexeon Europe